secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K/A
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001213900-23-051692
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 2.01, 3.02, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations completes reverse merger with CardioVentures; acquiree shows $3.4M loss, going concern doubt
--------------------------------------------------------------------------------

- Merger closed April 14, 2023; CardioVentures shareholders received 135.8M shares (≈95% of SSII post-merger).
- Dr. Sudhir Srivastava becomes controlling shareholder, Chairman and CEO; new management team appointed.
- CardioVentures 2022 revenue $1.46M, net loss $3.39M; accumulated deficit $3.7M.
- Auditor expresses substantial doubt about CardioVentures' ability to continue as going concern.
- Company issued 3.82M shares to Dr. Frederic Moll for $3M interim financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390023051692/0001213900-23-051692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390023051692/ea180745-8ka1_ssinnova.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-051692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer